Literature DB >> 27690734

Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016.

Qi Shi1, Wei Zhou1, Cao Chen1, Chen Gao1, Kang Xiao1, Jing Wang1, Bao-Yun Zhang1, Yuan Wang1, Feng Zhang1, Xiao-Ping Dong1,2.   

Abstract

The surveillance of CJD or human prion diseases (PrDs) has been conducted for 10 y in China. To evaluate the quality of China CJD surveillance system, the collections of the clinical and epidemiological information, the sampling, the clinical examinations and laboratory tests and follow-up survey were separately analyzed based on the data from 2010 to 2015. The obtaining rates of clinical-information table, epidemiological-information table, sample inspection sheet and medical record of the referring patients from reporting units to the center of CJD surveillance maintained or reached at very high levels, being close to 100% in the past 3 y. 93.82%, 85.23%, 96.21% and 94.70% of the reported cases had the data of MRI, EEG, CSF 14-3-3 and PRNP sequencing, respectively. Follow-up surveys were conducted in about 50% cases in 2010 and 2011, 93.39% cases in 2012 and 100% cases in the last 3 y. High obtaining rates of the clinical and epidemiological data, high conducting rates of the relevant clinical examinations and laboratory tests, high performing rates of follow-up survey for every referring case reflect a good implemental capacity in China CJD surveillance system, which supplies solid basis for recognition and diagnosis of human prion diseases and guarantees good quality of China CJD surveillance system.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; evaluation; human prion diseases; quality; surveillance

Mesh:

Substances:

Year:  2016        PMID: 27690734      PMCID: PMC5161297          DOI: 10.1080/19336896.2016.1229731

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  20 in total

1.  European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.

Authors:  I Zerr; J P Brandel; C Masullo; D Wientjens; R de Silva; M Zeidler; E Granieri; S Sampaolo; C van Duijn; N Delasnerie-Lauprêtre; R Will; S Poser
Journal:  J Clin Epidemiol       Date:  2000-07       Impact factor: 6.437

2.  Surveillance for Creutzfeldt-Jakob disease--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-08-09       Impact factor: 17.586

Review 3.  The end of the BSE saga: do we still need surveillance for human prion diseases?

Authors:  Herbert Budka; Robert G Will
Journal:  Swiss Med Wkly       Date:  2015-11-12       Impact factor: 2.193

4.  Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).

Authors:  H Budka; A Aguzzi; P Brown; J M Brucher; O Bugiani; F Gullotta; M Haltia; J J Hauw; J W Ironside; K Jellinger
Journal:  Brain Pathol       Date:  1995-10       Impact factor: 6.508

5.  Thorough work-up and new diagnostic criteria needed for CJD.

Authors:  David C Perry; Michael D Geschwind
Journal:  Nat Rev Neurol       Date:  2011-09-05       Impact factor: 42.937

6.  Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease.

Authors:  Qi Shi; Xiu-Chun Zhang; Wei Zhou; Kang Xiao; Cao Chen; Hai-Yan Zhang; Jing-Yi Sun; Li-Na Chen; Xiao-Mei Zhang; Jun Han; Xiao-Ping Dong
Journal:  Prion       Date:  2015       Impact factor: 3.931

Review 7.  The prion diseases.

Authors:  S B Prusiner
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

8.  The Features of Genetic Prion Diseases Based on Chinese Surveillance Program.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Bao-Yun Zhang; Kang Xiao; Xiu-Chun Zhang; Xiao-Jing Shen; Qing Li; Li-Quan Deng; Jian-Hua Dong; Wen-Qing Lin; Pu Huang; Wei-Jia Jiang; Jie Lv; Jun Han; Xiao-Ping Dong
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

9.  Overview and evaluation of 15 years of Creutzfeldt-Jakob disease surveillance in Belgium, 1998-2012.

Authors:  Amber Litzroth; Patrick Cras; Bart De Vil; Sophie Quoilin
Journal:  BMC Neurol       Date:  2015-12-02       Impact factor: 2.474

Review 10.  Epidemiological characteristics of human prion diseases.

Authors:  Cao Chen; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-06-02       Impact factor: 4.520

View more
  7 in total

1.  A Chinese patient of P102L Gerstmann-Sträussler-Scheinker disease contains three other disease-associated mutations in SYNE1.

Authors:  Jing Wang; Kang Xiao; Wei Zhou; Chen Gao; Cao Chen; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2018-04-02       Impact factor: 3.931

2.  Difference of geographic distributions of the Chinese patients with prion diseases in the permanent resident places and referring places.

Authors:  Kang Xiao; Ming-Fan Pang; Yue-Qiao Zhao; Li-Ping Gao; Yue-Zhang Wu; Yuan Wang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

3.  The associations of two SNPs in miRNA-146a and one SNP in ZBTB38-RASA2 with the disease susceptibility and the clinical features of the Chinese patients of sCJD and FFI.

Authors:  Chen Gao; Qiang Shi; Jing Wei; Wei Zhou; Kang Xiao; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2018-01-02       Impact factor: 3.931

4.  Analysis of 12 Chinese Patients with Proline-to-Leucine Mutation at Codon 102-Associated Gerstmann-Sträussler-Scheinker Disease.

Authors:  Jing Wang; Kang Xiao; Wei Zhou; Qi Shi; Xiao Ping Dong
Journal:  J Clin Neurol       Date:  2019-03-11       Impact factor: 3.077

5.  The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients.

Authors:  Li-Ping Gao; Qi Shi; Kang Xiao; Jing Wang; Wei Zhou; Cao Chen; Xiao-Ping Dong
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

Review 6.  Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior.

Authors:  Qiyong Liu; Wenbo Xu; Shan Lu; Jiafu Jiang; Jieping Zhou; Zhujun Shao; Xiaobo Liu; Lei Xu; Yanwen Xiong; Han Zheng; Sun Jin; Hai Jiang; Wuchun Cao; Jianguo Xu
Journal:  Front Med       Date:  2018-01-24       Impact factor: 4.592

7.  Evaluation of the effect of various main elements on the PrPSc detection by real-time quaking-induced conversion assay.

Authors:  Kang Xiao; Qi Shi; Wei Zhou; Chen Gao; Cao Chen; Bao-Yun Zhang; Jing Wang; Xiao-Ping Dong
Journal:  Int J Mol Med       Date:  2018-09-07       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.